An AirPod-Sized Wearable That Can Relieve Kids’ Gut Pain
A small device placed behind the ear targets the nervous system to help reduce pain and provide relief for kids with irritable bowel syndrome (IBS).
University of California San Francisco
Give to UCSFA small device placed behind the ear targets the nervous system to help reduce pain and provide relief for kids with irritable bowel syndrome (IBS).
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
Camp Winning Hands is a free summer camp for kids and teens with limb differences, where campers enjoy all types of activities that are modified for their unique conditions.
UCSF students and postdocs join advocates from around the country for the 2023 Rally for Medical Research to call on our nation’s policymakers to make funding for NIH a national priority and raise awareness about the importance of continued investment in medical research.
Vizient Inc. has named UCSF Health as a Top Performer for its high-quality patient care in the 2023 Bernard A. Birnbaum, MD, Quality Leadership Ranking.
Laura Persson, PhD, wins the 2023 Postdoc Slam with her talk titled “The Wormnado: What a tiny worm can teach us about collective behavior.”
UCSF has been given the green light on a new research and academic building at Parnassus Heights, creating a vital collaborative space to drive innovations in scientific research and education.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
Discoveries result from a mix of smarts, creativity, grit, collaboration, serendipity and time. But when scientists must constantly apply for funding, that last factor can be hard to come by. The Arc
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.